The mechanism behind the category declines is not appetite suppression, and it is not a shift toward wellness. It is the loss of the amplification that made these foods desirable.
Starting in the 1980s, the industry systematically applied what food scientists came to call the Bliss Point: the precise calibration of salt, sugar, and fat to keep consumers eating past the point of genuine satiation. The industry operationalized it at scale. The result was a food supply engineered not to satisfy but to sustain the craving for the next unit.
The Cornell University study, published in the Journal of Marketing Research in December 2025, matched survey data on GLP-1 use with Numerator purchase records from a nationally representative panel of about 150,000 households. Within six months of adoption, grocery spending fell 5.3%. The declines were not spread evenly.
Savory snacks fell approximately 10%. Sweets, baked goods, and cookies followed. Yogurt, fresh fruit, nutrition bars, and meat snacks held or grew.
Research presented at the European Association for the Study of Diabetes Annual Meeting in 2025 found that roughly one in five users on semaglutide or tirzepatide reported heightened intensity of sweet and salty tastes after starting the medication. When that amplification increased, single-note products did not become more appealing. They became harder to finish. The salt hit on a chip calibrated for a quieter palate becomes overwhelming on a sensitized one. The Cornell spend data confirms the behavioral outcome: the categories built on amplified signal contracted. The categories built on genuine sensory structure held.
A chip without the salt hit is starch. A cookie without the sugar is flour. Once the amplification dropped, the products built on it had nothing left to offer.
GLP-1 users are not a perfect proxy for the entire market. They are a leading indicator of what happens when engineered signal is interrupted. Private label sales hit a record $271 billion in 2024, growing nearly four times faster than national brands, per PLMA citing Circana data. Price drove consumers there first. Quality retention is what kept them. The GLP-1 cohort is the leading edge of a broader consumer recalibration already visible in the aggregate data.